Childress Capital Advisors LLC Takes $232,000 Position in HCA Healthcare, Inc. $HCA

Childress Capital Advisors LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 605 shares of the company's stock, valued at approximately $232,000.

A number of other large investors have also modified their holdings of HCA. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $26,000. Saudi Central Bank acquired a new position in HCA Healthcare in the first quarter worth about $26,000. WPG Advisers LLC acquired a new position in HCA Healthcare in the first quarter worth about $27,000. Atwood & Palmer Inc. acquired a new position in shares of HCA Healthcare in the 1st quarter worth approximately $28,000. Finally, Bartlett & CO. Wealth Management LLC raised its stake in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have issued reports on HCA. Cantor Fitzgerald reiterated an "overweight" rating and set a $444.00 price objective on shares of HCA Healthcare in a research note on Tuesday, August 26th. Morgan Stanley dropped their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Barclays raised their price target on HCA Healthcare from $390.00 to $445.00 and gave the company an "overweight" rating in a report on Thursday, September 18th. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Finally, Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $407.75.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

NYSE HCA opened at $425.85 on Thursday. The stock has a fifty day moving average of $393.90 and a 200-day moving average of $371.02. The stock has a market capitalization of $99.64 billion, a P/E ratio of 17.90, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $429.43.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the company earned $5.50 earnings per share. The company's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.